S&P 500   5,123.41
DOW   37,983.24
QQQ   438.27
5 Semiconductor Giants: Navigating the Recent Pullback
3 Key Stocks Helping to Drive the EV Race
Breakout Alert: Coinbase's Consolidation Is About To End
You Can Follow BlackRock’s Market View for Your Money
Closing prices for crude oil, gold and other commodities
JPMorgan Chase Falls 5% as Consumer Cracking Begins to Show
JPMorgan Chase, Advanced Micro Devices fall; Progressive, State Street rise, 4/12/2024
S&P 500   5,123.41
DOW   37,983.24
QQQ   438.27
5 Semiconductor Giants: Navigating the Recent Pullback
3 Key Stocks Helping to Drive the EV Race
Breakout Alert: Coinbase's Consolidation Is About To End
You Can Follow BlackRock’s Market View for Your Money
Closing prices for crude oil, gold and other commodities
JPMorgan Chase Falls 5% as Consumer Cracking Begins to Show
JPMorgan Chase, Advanced Micro Devices fall; Progressive, State Street rise, 4/12/2024
S&P 500   5,123.41
DOW   37,983.24
QQQ   438.27
5 Semiconductor Giants: Navigating the Recent Pullback
3 Key Stocks Helping to Drive the EV Race
Breakout Alert: Coinbase's Consolidation Is About To End
You Can Follow BlackRock’s Market View for Your Money
Closing prices for crude oil, gold and other commodities
JPMorgan Chase Falls 5% as Consumer Cracking Begins to Show
JPMorgan Chase, Advanced Micro Devices fall; Progressive, State Street rise, 4/12/2024
S&P 500   5,123.41
DOW   37,983.24
QQQ   438.27
5 Semiconductor Giants: Navigating the Recent Pullback
3 Key Stocks Helping to Drive the EV Race
Breakout Alert: Coinbase's Consolidation Is About To End
You Can Follow BlackRock’s Market View for Your Money
Closing prices for crude oil, gold and other commodities
JPMorgan Chase Falls 5% as Consumer Cracking Begins to Show
JPMorgan Chase, Advanced Micro Devices fall; Progressive, State Street rise, 4/12/2024
NASDAQ:MORF

Morphic (MORF) Stock Price, News & Analysis

$28.66
-1.66 (-5.47%)
(As of 04/12/2024 ET)
Today's Range
$28.23
$30.01
50-Day Range
$28.66
$40.31
52-Week Range
$19.34
$63.08
Volume
457,813 shs
Average Volume
355,189 shs
Market Capitalization
$1.43 billion
P/E Ratio
N/A
Dividend Yield
N/A
Price Target
$61.00

Morphic MarketRank™ Stock Analysis

Analyst Rating
Moderate Buy
2.67 Rating Score
Upside/​Downside
112.8% Upside
$61.00 Price Target
Short Interest
Bearish
11.79% of Shares Sold Short
Dividend Strength
N/A
Sustainability
-0.57
Upright™ Environmental Score
News Sentiment
0.91mentions of Morphic in the last 14 days
Based on 2 Articles This Week
Insider Trading
Selling Shares
$986,231 Sold Last Quarter
Proj. Earnings Growth
Decreasing
From ($3.90) to ($4.26) Per Share

Overall MarketRank

New Rank-Based ScoringMarketRank is calculated by averaging available category scores (with extra weight given to analysis and valuation), then ranking the company's weighted average against that of other companies.

3.87 out of 5 stars

Medical Sector

213th out of 923 stocks

Pharmaceutical Preparations Industry

85th out of 424 stocks

MORF stock logo

About Morphic Stock (NASDAQ:MORF)

Morphic Holding, Inc., a biopharmaceutical company, discovers and develops oral small-molecule integrin therapeutics for the treatment of autoimmune, cardiovascular, and metabolic diseases, as well as fibrosis and cancer. Its lead product candidate MORF-057, an a4ß7-specific integrin inhibitor affecting inflammation is in Phase 2 clinical trials for the treatment of inflammatory bowel disease. The company's products in pipeline include Next Gen a4ß7 Inhibitors for additional potential GI indications, such as EGIDs, pouchitis, etc.; avß8 for the treatment of Myelofibrosis and solid tumor; and fibronectin integrin for pulmonary hypertensive. In addition, it has a license agreement with Janssen to discover and develop novel integrin therapeutics; collaboration agreement with Schrödinger for integrin targets; and license agreement with Children's Medical Center Corporation to develop and commercialize products worldwide for any therapeutic or diagnostic use in humans and veterinary applications. Morphic Holding, Inc. was incorporated in 2014 and is headquartered in Waltham, Massachusetts.

MORF Stock Price History

MORF Stock News Headlines

Bitcoin Rockets To Record High But Buy THIS Instead
Recently, Bitcoin smashed through its previous record high to hit $72,720. It’s made many, many people very rich. But one cryptocurrency expert and investing millionaire is declaring…
Morphic Appoints Simon Cooper As Chief Medical Officer
MORF Jul 2024 17.500 put
Bitcoin Rockets To Record High But Buy THIS Instead
Recently, Bitcoin smashed through its previous record high to hit $72,720. It’s made many, many people very rich. But one cryptocurrency expert and investing millionaire is declaring…
MORF Apr 2024 50.000 call
MORF Apr 2024 20.000 put
MORF Jul 2024 40.000 call
Morphic to Participate in March Investor Conferences
MORF Jul 2024 30.000 call
Recap: Morphic Holding Q4 Earnings
New Strong Buy Stocks for February 14th
See More Headlines
Receive MORF Stock News and Ratings via Email

Sign-up to receive the latest news and ratings for Morphic and its competitors with MarketBeat's FREE daily newsletter.

Company Calendar

Last Earnings
2/22/2024
Today
4/12/2024
Next Earnings (Estimated)
4/23/2024
Fiscal Year End
12/31/2024

Industry, Sector and Symbol

Sector
Medical
Industry
Pharmaceutical preparations
Sub-Industry
N/A
Current Symbol
NASDAQ:MORF
Fax
N/A
Employees
121
Year Founded
N/A

Price Target and Rating

Average Stock Price Target
$61.00
High Stock Price Target
$80.00
Low Stock Price Target
$33.00
Potential Upside/Downside
+112.8%
Consensus Rating
Moderate Buy
Rating Score (0-4)
2.67
Research Coverage
6 Analysts

Profitability

Net Income
$-152,100,000.00
Pretax Margin
-29,119.96%

Debt

Sales & Book Value

Annual Sales
$520,000.00
Book Value
$14.01 per share

Miscellaneous

Free Float
35,977,000
Market Cap
$1.43 billion
Optionable
Optionable
Beta
1.42
The Next 7 Blockbuster Stocks for Growth Investors Cover

Wondering what the next stocks will be that hit it big, with solid fundamentals? Click the link below to learn more about how your portfolio could bloom.

Get This Free Report

Key Executives

  • Dr. Bruce N. Rogers Ph.D. (Age 55)
    President & Interim Principal Executive Officer
    Comp: $787.88k
  • Dr. Timothy A. Springer Ph.D. (Age 76)
    Founder, Independent Director & Member of Scientific Advisory Board
    Comp: $40k
  • Dr. Marc Schegerin M.B.A. (Age 48)
    M.D., CFO & COO
    Comp: $722.38k
  • Dr. Praveen P. Tipirneni M.D. (Age 55)
    CEO, MD & Director (Leave of Absence)
    Comp: $991.33k
  • Mr. Robert E. Farrell Jr.Mr. Robert E. Farrell Jr. (Age 59)
    CPA, Senior VP of Finance & Chief Accounting Officer
  • Dr. Blaise Lippa Ph.D.
    Chief Scientific Officer
  • Mr. William D. DeVaul Esq. (Age 53)
    General Counsel & Secretary
    Comp: $601.44k
  • Mr. Aaron Pelta
    Senior Vice President of Business & Corporate Development
  • Ms. Joanne Gibbons
    Senior Vice President of Regulatory Affairs

MORF Stock Analysis - Frequently Asked Questions

Should I buy or sell Morphic stock right now?

6 Wall Street analysts have issued "buy," "hold," and "sell" ratings for Morphic in the last year. There are currently 2 hold ratings and 4 buy ratings for the stock. The consensus among Wall Street analysts is that investors should "moderate buy" MORF shares.
View MORF analyst ratings
or view top-rated stocks.

What is Morphic's stock price target for 2024?

6 Wall Street analysts have issued 1 year price objectives for Morphic's shares. Their MORF share price targets range from $33.00 to $80.00. On average, they predict the company's stock price to reach $61.00 in the next year. This suggests a possible upside of 112.8% from the stock's current price.
View analysts price targets for MORF
or view top-rated stocks among Wall Street analysts.

How have MORF shares performed in 2024?

Morphic's stock was trading at $28.88 at the start of the year. Since then, MORF stock has decreased by 0.8% and is now trading at $28.66.
View the best growth stocks for 2024 here
.

When is Morphic's next earnings date?

The company is scheduled to release its next quarterly earnings announcement on Tuesday, April 23rd 2024.
View our MORF earnings forecast
.

How were Morphic's earnings last quarter?

Morphic Holding, Inc. (NASDAQ:MORF) posted its earnings results on Thursday, February, 22nd. The company reported ($0.94) earnings per share for the quarter, missing analysts' consensus estimates of ($0.89) by $0.05.

What other stocks do shareholders of Morphic own?
When did Morphic IPO?

Morphic (MORF) raised $75 million in an IPO on Thursday, June 27th 2019. The company issued 5,000,000 shares at $14.00-$16.00 per share. Jefferies, Cowen, BMO Capital Markets and Wells Fargo Securities acted as the underwriters for the IPO.

How do I buy shares of Morphic?

Shares of MORF stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Charles Schwab, E*TRADE, Fidelity, and Vanguard Brokerage Services.
Compare Top Brokerages Here.

This page (NASDAQ:MORF) was last updated on 4/13/2024 by MarketBeat.com Staff

From Our Partners